相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
Josef Coresh et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes
B. Schievink et al.
DIABETES OBESITY & METABOLISM (2016)
The Strength of Association Between Surrogate End Points and Survival in Oncology A Systematic Review of Trial-Level Meta-analyses
Vinay Prasad et al.
JAMA INTERNAL MEDICINE (2015)
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
Kunihiro Matsushita et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials
Lesley A. Inker et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Andrew S. Levey et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
Josef Coresh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine
Claudio Pozzi et al.
JOURNAL OF NEPHROLOGY (2013)
Change in the estimated glomerular filtration rate over time and risk of all-cause mortality
Tanvir C. Turin et al.
KIDNEY INTERNATIONAL (2013)
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation
Hicham Skali et al.
AMERICAN HEART JOURNAL (2011)
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts
Ron T. Gansevoort et al.
KIDNEY INTERNATIONAL (2011)
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts
Brad C. Astor et al.
KIDNEY INTERNATIONAL (2011)
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts
Marije van der Velde et al.
KIDNEY INTERNATIONAL (2011)
Feature Selection with the Boruta Package
Miron B. Kursa et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Addition of Azathioprine to Corticosteroids Does Not Benefit Patients with IgA Nephropathy
Claudio Pozzi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy
Carlo Manno et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Hong Kong study using valsartan in IgA nephropathy (HKVIN): A double-blind, randomized, placebo-controlled study
Philip Kam-Tao Li et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy
C Ponticelli et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy:: a double-blind randomized controlled trial
G Frisch et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial
C Pozzi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study
BD Maes et al.
KIDNEY INTERNATIONAL (2004)
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK)
JJ Gassman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Treatment of IgA nephropathy with ACE inhibitors:: A Randomized and controlled trial
M Praga et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Controlled, prospective trial of steroid treatment in IgA nephropathy: A limitation of low-dose prednisolone therapy
R Katafuchi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease - Results from the AASK trial
JT Wright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
